Case T-273/03: Judgment of the Court of First Instance (Fifth Chamber) of 31 January 2006 — Merck Sharp %amp% Dohme and Others v Commission (Medicinal products for human use — Marketing authorisation for products containing the substance enalapril — Commission decision ordering amendment of the summary of the product's characteristics — Competence) 
Judgment of the Court of First Instance (Fifth Chamber) of 31 January 2006 — Merck Sharp %amp% Dohme and Others v Commission 
(Case T-273/03) [1] 
Parties 
Applicant(s): Merck Sharp %amp% Dohme Ltd (Hoddesdon, United Kingdom), Merck Sharp %amp% Dohme BV (Haarlem, Netherlands), Laboratoires Merck Sharp %amp% Dohme-Chibret (Paris, France), MSD Sharp %amp% Dohme GmbH (Haar, Germany), Merck Sharp %amp% Dohme (Italia) SpA (Rome, Italy), Merck Sharp %amp% Dohme, Lda (Paço de Arcos, Portugal), Merck Sharp %amp% Dohme de España, SA (Madrid, Spain), Merck Sharp %amp% Dohme GmbH (Vienna, Austria), Vianex SA (Nea Erythrea, Greece), (represented by: G. Berrisch and P. Bogaert, lawyers) 
Defendant: Commission of the European Communities (represented by: L. Flynn and B. Stromsky, Agents) 
Action for 
annulment of Commission Decision C(2003) 1752 of 21 May 2003 on the marketing of medicinal products for human use containing the substance enalapril 
Operative part of the judgment 
The Court: 
1. Annuls Commission Decision C(2003) 1752 of 21 May 2003 on the marketing of medicinal products for human use containing the substance enalapril; 
2. Orders the Commission to pay the costs. 
[1] OJ C 251, 18.10.2003. 
-------------------------------------------------- 
